Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study
Houot, Roch, Cartron, Guillaume, Bijou, Fontanet, de Guibert, Sophie, Salles, Gilles A., Fruchart, Christophe, Bouabdallah, Krimo, Maerevoet, Marie, Feugier, Pierre, Le Gouill, Steven, Tilly, Hervé, CLanguage:
english
Journal:
Leukemia
DOI:
10.1038/s41375-018-0282-y
Date:
October, 2018
File:
PDF, 839 KB
english, 2018